Low-energy amplitude-modulated radiofrequency electromagnetic fields as a systemic treatment for cancer: Review and proposed mechanisms of action
This review discusses low-energy amplitude-modulated RF EMF (27.12 MHz carrier with low Hz–kHz envelope modulation) delivered systemically via intrabuccal antenna devices as a potential treatment for advanced hepatocellular carcinoma. It reports preclinical inhibition of cancer growth in vitro and in mouse xenograft models using tumor- or patient-specific frequencies. It also summarizes uncontrolled prospective clinical trials in which a minority of AHCC patients had complete or partial responses and pooled comparisons suggested improved overall survival versus historical controls, with mild transient somnolence as the main reported adverse event.
Key points
- The paper reviews LEAMRFEMF as a systemic RF-EMF-based treatment approach for advanced hepatocellular carcinoma.
- Devices described use a 27.12 MHz carrier wave with amplitude modulation producing low Hz to kHz envelope waves.
- Exposure is delivered systemically via an intrabuccal antenna, and one device uses patient-specific frequencies.
- The abstract reports inhibition of human cancer cell line growth in vitro and reduced growth in mouse xenograft models at specific frequencies.
- Uncontrolled prospective clinical trials are described where a minority of AHCC patients experienced complete or partial tumor responses.
- Pooled comparisons are reported to show enhanced overall survival versus historical controls, and mild transient somnolence is noted as the main adverse event.
- Proposed mechanisms include resonant coupling affecting charged macromolecules/ion flows, disrupting cell division and mitochondrial trafficking, and potentially shifting metabolism away from glycolysis.
Referenced studies & papers
Relevant papers in OpenMel
Source:
Open original
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
Comments
Log in to comment.
No comments yet.